Clinical features of patients with PTCL-NOS
| Characteristic . | Value . |
|---|---|
| Median age, y | 60 |
| Male:female ratio | 1.9:1 |
| Stage, % (n/N) | |
| I | 14 (45/334) |
| II | 17 (57/334) |
| III | 26 (87/334) |
| IV | 43 (145/334) |
| B symptoms, % (n/N) | 35 (118/340) |
| Performance status ≥ 2, % (n/N) | 18 (60/334) |
| Elevated serum LDH, % (n/N) | 49 (158/323) |
| Extranodal sites > 1, % (n/N) | 29 (99/340) |
| Bone marrow positive, % (n/N) | 21 (68/322) |
| Bulky disease ≥ 10 cm, % (n/N) | 7 (19/285) |
| Platelets < 150 × 109/L, % (n/N) | 24 (64/266) |
| Hypergammaglobulinemia, % (n/N) | 14 (29/201) |
| Characteristic . | Value . |
|---|---|
| Median age, y | 60 |
| Male:female ratio | 1.9:1 |
| Stage, % (n/N) | |
| I | 14 (45/334) |
| II | 17 (57/334) |
| III | 26 (87/334) |
| IV | 43 (145/334) |
| B symptoms, % (n/N) | 35 (118/340) |
| Performance status ≥ 2, % (n/N) | 18 (60/334) |
| Elevated serum LDH, % (n/N) | 49 (158/323) |
| Extranodal sites > 1, % (n/N) | 29 (99/340) |
| Bone marrow positive, % (n/N) | 21 (68/322) |
| Bulky disease ≥ 10 cm, % (n/N) | 7 (19/285) |
| Platelets < 150 × 109/L, % (n/N) | 24 (64/266) |
| Hypergammaglobulinemia, % (n/N) | 14 (29/201) |
LDH indicates lactate dehydrogenase.